货号 |
中文名称 |
英文名词 |
靶点 |
VAPD00144 |
替奈昔单抗
|
Research Grade Teneliximab Biosimilar |
CD40, TNFRSF5,B-cell surface antigen CD40 |
VAPD00143 |
依美昔单抗
|
Research Grade Ecromeximab Biosimilar |
Disialoganglioside GD3, GD3 ganglioside, α-N-acetylneuraminosyl-(2→8)-α-N-acetylneuraminosyl-(2→3)-β |
VAPD00142 |
Research Grade tositumomab Biosimilar
|
|
MS4A1, CD20, B-lymphocyte antigen CD20 |
VAPD00141 |
Research Grade epitumomab cituxetan Biosimilar
|
|
MUC1, MUC-1, PEM, PUM, PEMT, H23AG, EMA, CD227, Mucin-1, |
VAPD00140 |
Research Grade Epitumomab ( 西依匹莫单抗 ) Biosimilar
|
|
MS4A1, CD20, B-lymphocyte antigen CD20 |
VAPD00139 |
艾西莫单抗
|
Research Grade Elsilimomab Biosimilar |
IL6, IFNB2, BSF-2, CDF, Interleukin-6, IL-6, IFN-beta-2 |
VAPD00138 |
贝利木单抗
|
Research Grade Belimumab Biosimilar |
TNFSF13B, BAFF, BLyS, TALL-1, TNFSF20, ZTNF4, CD257 |
VAPD00137 |
乌珠单抗
|
Research Grade Urtoxazumab ( 乌珠单抗 ) Biosimilar |
shiga toxin type 2, stx2, Stx2, Stx-2, Shiga-like toxin 2 |
VAPD00136 |
利韦单抗
|
Research Grade Libivirumab ( 利韦单抗 ) Biosimilar |
HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus] |
VAPD00135 |
艾韦单抗
|
Research Grade Exbivirumab Biosimilar |
HBV (hepatitis B virus) surface antigen (HBsAg) [Hepatitis B virus] |